New-Onset Cardiovascular Complications Common After Stroke
THURSDAY, March 31, 2022 -- New-onset cardiovascular complications diagnosed after ischemic stroke are common and are associated with worse long-term prognosis, according to a study published online March 31 in Stroke.
Benjamin J.R. Buckley, Ph.D.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 31, 2022 Category: Pharmaceuticals Source Type: news
Fewer Than Half of Stroke Patients Receive Indicated DAPT Fewer Than Half of Stroke Patients Receive Indicated DAPT
Fewer than half of ischemic stroke patients whom guidelines say should get dual-antiplatelet therapy (DAPT) actually receive the treatment, a new study suggests.Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - March 31, 2022 Category: Intensive Care Tags: Cardiology News Source Type: news
Drugs Used for Nausea/Vomiting Linked to Stroke Risk Drugs Used for Nausea/Vomiting Linked to Stroke Risk
Antidopaminergic antiemetics (ADAs) used to relieve nausea and vomiting, including that induced by chemotherapy or radiotherapy, have been associated with an increased risk of ischemic stroke.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 29, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Risk for Ischemic Stroke Up With Antidopaminergic Antiemetic Use
Increase in risk greatest for metopimazine and metoclopramide; risk for ischemic stroke may be higher in first days of use (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - March 29, 2022 Category: Cancer & Oncology Tags: Cardiology, Family Medicine, Gastroenterology, Internal Medicine, Neurology, Oncology, Pharmacy, Journal, Source Type: news
Risk for Ischemic Stroke Up With Antidopaminergic Antiemetic Use
TUESDAY, March 29, 2022 -- The risk for ischemic stroke is increased in association with the use of antidopaminergic antiemetics (ADAs), according to a study published online March 23 in The BMJ.
Anne B énard-Laribière, from the University of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 29, 2022 Category: Pharmaceuticals Source Type: news
Commonly prescribed anti-nausea drugs may TRIPLE the risk of a stroke, study suggests
French researchers claim to have found that patients on commonly prescribed ant-nausea drugs are three times as likely to suffer an ischemic stroke in a study of nearly 30,000 patients. (Source: the Mail online | Health)
Source: the Mail online | Health - March 23, 2022 Category: Consumer Health News Source Type: news
Widely used anti-nausea drugs raise risk for ischemic stroke, study finds
A class of commonly used drugs designed to relieve nausea and vomiting caused by migraine, cancer treatment or surgery has been linked with an increased risk for ischemic stroke, a study published by the BMJ found. (Source: Health News - UPI.com)
Source: Health News - UPI.com - March 23, 2022 Category: Consumer Health News Source Type: news
Stroke: OCD could make people 'three times as likely to have an ischemic stroke'
STROKES occur when blood supply to part of the brain gets interrupted. When this happens the brain tissue stops getting oxygen and nutrients and its cells quickly die. Among the major risk factors for strokes are an unhealthy lifestyle and preexisting conditions like heart disease and diabetes. A new study has revealed that having OCD too could increase the risk of stroke. (Source: Daily Express - Health)
Source: Daily Express - Health - March 10, 2022 Category: Consumer Health News Source Type: news
Antithrombotics Harmful During Stroke Thrombectomy: MR CLEAN-MED Antithrombotics Harmful During Stroke Thrombectomy: MR CLEAN-MED
The use of aspirin or heparin during treatment of acute ischemic stroke was associated with an increased risk of intracranial hemorrhage without evidence for a beneficial effect on functional outcome.Medscape Medical News (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - March 4, 2022 Category: Intensive Care Tags: Cardiology News Source Type: news
Are Thrombolytics for Stroke Safe for Patients on NOACs? Are Thrombolytics for Stroke Safe for Patients on NOACs?
A retrospective analysis suggests that recent NOAC use is not associated with increased risk for symptomatic intracranial hemorrhage after treatment with IV alteplase for acute ischemic stroke.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - February 25, 2022 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news
NOAC Use Not Tied to ICH in Stroke Patients Treated With Alteplase
FRIDAY, Feb. 25, 2022 -- For patients with acute ischemic stroke receiving alteplase, use of non-vitamin K antagonist oral anticoagulants (NOACs) in the previous seven days is not associated with an increased risk for intracranial hemorrhage... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 25, 2022 Category: Pharmaceuticals Source Type: news
Atrial Fib, Elevated Lipids Raise Stroke Risk in Cancer Patients Atrial Fib, Elevated Lipids Raise Stroke Risk in Cancer Patients
New-onset or pre-existing AF predicted acute ischemic stroke or TIA in patients with cancer -- as did renal disease, dyslipidemia, and active cancer therapy -- in a case-control study.First Look (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 24, 2022 Category: Cancer & Oncology Tags: Cardiology News Source Type: news
More Intensive LDL-C Lowering May Cut Recurrent Stroke Risk
TUESDAY, Feb. 22, 2022 -- Among patients with a history of ischemic stroke, more intensive low-density lipoprotein cholesterol (LDL-C)-lowering statin-based therapies are associated with a decreased risk for recurrent stroke but an increased risk... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 22, 2022 Category: Pharmaceuticals Source Type: news
Poor Outcomes Common With COVID - 19, Acute Ischemic Stroke
Factors associated with poor functional outcomes included age older than 60 years, diabetes mellitus, increased NIHSS, LVO (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - February 18, 2022 Category: Respiratory Medicine Tags: Cardiology, Infections, Neurology, Pulmonology, Critical Care, Emergency Medicine, Journal, Source Type: news
Poor Outcomes Common With COVID-19, Acute Ischemic Stroke
FRIDAY, Feb. 18, 2022 -- About half of patients with COVID-19 with acute ischemic stroke (AIS) have poor outcomes, with 38.8 percent mortality, according to a study recently published in the Journal of Neurology, Neurosurgery& Psychiatry.
Adam... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 18, 2022 Category: Pharmaceuticals Source Type: news
